Certified by Founder Lodge
Trinity Innovation Fund
China - Beijing
INVESTOR
1 Disclosed Funding Rounds $38,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in 2018, Trinity Innovation Fund (TIF) is dedicated to investing on biomedical innovations. Currently we are managing two funds with different focuses. Our limited partners (LPs) incl
| Company | Date | Round | Raised |
|---|---|---|---|
Adcentrx Therapeutics |
April, 25 ,2023 | Series A | $38,000,000 |
Adcentrx Therapeutics
dezerv.
FalconX
Kristal.AI
Finary
Savart
Naoma AI | $440,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)